BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
23 results:

  • 1. Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
    Delagnes A; Roux M; Vilgrain V; Guiu B; Laurent V; Sutter O; Bricault I; Trillaud H; Aubé C; Paisant A
    Eur Radiol; 2024 Apr; 34(4):2283-2293. PubMed ID: 37816923
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A targetable lifr-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.
    Yao F; Deng Y; Zhao Y; Mei Y; Zhang Y; Liu X; Martinez C; Su X; Rosato RR; Teng H; Hang Q; Yap S; Chen D; Wang Y; Chen MM; Zhang M; Liang H; Xie D; Chen X; Zhu H; Chang JC; You MJ; Sun Y; Gan B; Ma L
    Nat Commun; 2021 Dec; 12(1):7333. PubMed ID: 34921145
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting lifr.
    Tan W; Li Z; Xia W; Zhu J; Fan R
    Ann Hepatol; 2022 Jan; 27 Suppl 1():100567. PubMed ID: 34699986
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
    Owusu Sekyere S; Port K; Deterding K; Cornberg M; Wedemeyer H
    United European Gastroenterol J; 2021 May; 9(4):486-496. PubMed ID: 33349201
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Point shear wave speed measurement in differentiating benign and malignant focal liver lesions.
    Dong Y; Wang WP; Xu Y; Cao J; Mao F; Dietrich CF
    Med Ultrason; 2017 Jun; 19(3):259-264. PubMed ID: 28845490
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
    Chan SL; Yeo W; Mo F; Chan AWH; Koh J; Li L; Hui EP; Chong CCN; Lai PBS; Mok TSK; Yu SCH
    Cancer; 2017 Oct; 123(20):3977-3985. PubMed ID: 28640364
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. lifr functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
    Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
    Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.
    Luo Q; Zhang Y; Wang N; Jin G; Jin H; Gu D; Tao X; Huo X; Ge T; Cong W; Wang C; Qin W
    Oncotarget; 2015 Mar; 6(9):6989-99. PubMed ID: 25749520
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Our initial experience with ALPPS technique: encouraging results.
    Sala S; Ardiles V; Ulla M; Alvarez F; Pekolj J; de Santibañes E
    Updates Surg; 2012 Sep; 64(3):167-72. PubMed ID: 22903531
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma.
    Wang Z; Zheng T; Wu Q; Wang J; Wu C; Wang J
    Neoplasma; 2012; 59(2):137-41. PubMed ID: 22248270
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Leukemia inhibitory factor receptor (lifr) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
    Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas.
    Wysoczynski M; Miekus K; Jankowski K; Wanzeck J; Bertolone S; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Cancer Res; 2007 Mar; 67(5):2131-40. PubMed ID: 17332343
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Prevalence of hepatitis B virus core promoter mutant isolated from asymptomatic carriers from areas with higher and lower incidence of hepatocellular carcinoma in Guangxi].
    Fang ZL; Zhuang H; Wang YC; Ge XM; Yang JY; Gong J; Li RC; Ling R; Harrison TJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):140-2. PubMed ID: 12869995
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130.
    Neddermann P; Graziani R; Ciliberto G; Paonessa G
    J Biol Chem; 1996 Nov; 271(48):30986-91. PubMed ID: 8940087
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.